XPENG INC - ADR (XPEV) Fundamental Analysis & Valuation

NYSE:XPEV • US98422D1054

Current stock price

15.9 USD
-1.07 (-6.31%)
At close:
16.39 USD
+0.49 (+3.08%)
Pre-Market:

This XPEV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. XPEV Profitability Analysis

1.1 Basic Checks

  • XPEV had negative earnings in the past year.
  • XPEV had negative earnings in each of the past 5 years.
  • In the past 5 years XPEV reported 4 times negative operating cash flow.
XPEV Yearly Net Income VS EBIT VS OCF VS FCFXPEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 -2B -4B -6B -8B -10B

1.2 Ratios

  • XPEV has a better Return On Assets (-1.10%) than 71.43% of its industry peers.
  • The Return On Equity of XPEV (-3.75%) is better than 68.57% of its industry peers.
Industry RankSector Rank
ROA -1.1%
ROE -3.75%
ROIC N/A
ROA(3y)-6.81%
ROA(5y)-8.12%
ROE(3y)-16.94%
ROE(5y)-17.43%
ROIC(3y)N/A
ROIC(5y)N/A
XPEV Yearly ROA, ROE, ROICXPEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • XPEV has a better Gross Margin (19.35%) than 80.00% of its industry peers.
  • In the last couple of years the Gross Margin of XPEV has grown nicely.
  • XPEV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.02%
GM growth 5Y21.18%
XPEV Yearly Profit, Operating, Gross MarginsXPEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 -5K -10K -15K -20K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. XPEV Health Analysis

2.1 Basic Checks

  • XPEV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for XPEV has been increased compared to 1 year ago.
  • The number of shares outstanding for XPEV has been increased compared to 5 years ago.
  • XPEV has a worse debt/assets ratio than last year.
XPEV Yearly Shares OutstandingXPEV Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
XPEV Yearly Total Debt VS Total AssetsXPEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • Based on the Altman-Z score of 1.01, we must say that XPEV is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of XPEV (1.01) is better than 65.71% of its industry peers.
  • XPEV has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.
  • XPEV has a Debt to Equity ratio of 1.01. This is comparable to the rest of the industry: XPEV outperforms 42.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Altman-Z 1.01
ROIC/WACCN/A
WACC8.39%
XPEV Yearly LT Debt VS Equity VS FCFXPEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B 30B 40B

2.3 Liquidity

  • XPEV has a Current Ratio of 1.09. This is a normal value and indicates that XPEV is financially healthy and should not expect problems in meeting its short term obligations.
  • XPEV has a Current ratio of 1.09. This is comparable to the rest of the industry: XPEV outperforms 42.86% of its industry peers.
  • A Quick Ratio of 0.91 indicates that XPEV may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.91, XPEV is in line with its industry, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.91
XPEV Yearly Current Assets VS Current LiabilitesXPEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. XPEV Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 80.36% over the past year.
  • The Revenue has grown by 87.73% in the past year. This is a very strong growth!
  • Measured over the past years, XPEV shows a very strong growth in Revenue. The Revenue has been growing by 67.35% on average per year.
EPS 1Y (TTM)80.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
Revenue 1Y (TTM)87.73%
Revenue growth 3Y41.89%
Revenue growth 5Y67.35%
Sales Q2Q%38.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 47.31% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, XPEV will show a quite strong growth in Revenue. The Revenue will grow by 17.61% on average per year.
EPS Next Y51.08%
EPS Next 2Y102.55%
EPS Next 3Y77.3%
EPS Next 5Y47.31%
Revenue Next Year22.9%
Revenue Next 2Y24.44%
Revenue Next 3Y19.03%
Revenue Next 5Y17.61%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
XPEV Yearly Revenue VS EstimatesXPEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50B 100B 150B 200B
XPEV Yearly EPS VS EstimatesXPEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 -5 -10

More info and screens

Find the best growth stocksShow best growing peers

1

4. XPEV Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for XPEV. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XPEV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XPEV Price Earnings VS Forward Price EarningsXPEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XPEV Per share dataXPEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • XPEV's earnings are expected to grow with 77.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y102.55%
EPS Next 3Y77.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XPEV Dividend Analysis

5.1 Amount

  • No dividends for XPEV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XPEV Fundamentals: All Metrics, Ratios and Statistics

XPENG INC - ADR

NYSE:XPEV (4/23/2026, 8:04:00 PM)

Premarket: 16.39 +0.49 (+3.08%)

15.9

-1.07 (-6.31%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)03-20
Earnings (Next)05-21
Inst Owners10.85%
Inst Owner Change0.27%
Ins Owners0.25%
Ins Owner Change7.75%
Market Cap15.20B
Revenue(TTM)76.72B
Net Income(TTM)-1.14B
Analysts79.41
Price Target24.19 (52.14%)
Short Float %12.75%
Short Ratio7.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)111.64%
Min EPS beat(2)2.77%
Max EPS beat(2)220.52%
EPS beat(4)4
Avg EPS beat(4)76.48%
Min EPS beat(4)2.77%
Max EPS beat(4)220.52%
EPS beat(8)5
Avg EPS beat(8)39.55%
EPS beat(12)6
Avg EPS beat(12)23.68%
EPS beat(16)7
Avg EPS beat(16)13.65%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-1.42%
Max Revenue beat(2)-1.26%
Revenue beat(4)1
Avg Revenue beat(4)-0.85%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)2.52%
Revenue beat(8)2
Avg Revenue beat(8)-2.24%
Revenue beat(12)2
Avg Revenue beat(12)-4.19%
Revenue beat(16)3
Avg Revenue beat(16)-4.37%
PT rev (1m)-6.76%
PT rev (3m)-13.7%
EPS NQ rev (1m)-190.79%
EPS NQ rev (3m)-4418.92%
EPS NY rev (1m)-184.03%
EPS NY rev (3m)-136.82%
Revenue NQ rev (1m)-25.42%
Revenue NQ rev (3m)-40.18%
Revenue NY rev (1m)-6.39%
Revenue NY rev (3m)-13.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.35
P/FCF N/A
P/OCF N/A
P/B 3.42
P/tB 3.98
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS11.74
BVpS4.65
TBVpS4
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1.1%
ROE -3.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.35%
FCFM N/A
ROA(3y)-6.81%
ROA(5y)-8.12%
ROE(3y)-16.94%
ROE(5y)-17.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.02%
GM growth 5Y21.18%
F-ScoreN/A
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 0.91
Altman-Z 1.01
F-ScoreN/A
WACC8.39%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
EPS Next Y51.08%
EPS Next 2Y102.55%
EPS Next 3Y77.3%
EPS Next 5Y47.31%
Revenue 1Y (TTM)87.73%
Revenue growth 3Y41.89%
Revenue growth 5Y67.35%
Sales Q2Q%38.18%
Revenue Next Year22.9%
Revenue Next 2Y24.44%
Revenue Next 3Y19.03%
Revenue Next 5Y17.61%
EBIT growth 1Y62.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year150.4%
EBIT Next 3Y60.47%
EBIT Next 5Y45.9%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

XPENG INC - ADR / XPEV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for XPENG INC - ADR?

ChartMill assigns a fundamental rating of 3 / 10 to XPEV.


What is the valuation status for XPEV stock?

ChartMill assigns a valuation rating of 1 / 10 to XPENG INC - ADR (XPEV). This can be considered as Overvalued.


Can you provide the profitability details for XPENG INC - ADR?

XPENG INC - ADR (XPEV) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for XPEV stock?

The Earnings per Share (EPS) of XPENG INC - ADR (XPEV) is expected to grow by 51.08% in the next year.